These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4222809)

  • 21. STUDIES OF THE PEPTIC DEGRADATION OF BOVINE BRADYKININOGEN.
    GREENBAUM LM; YAMAFUJI K; HOSODA T
    Biochem Pharmacol; 1965 Apr; 14():411-20. PubMed ID: 14322967
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the kinin formation by bovine spleen acid kininogenases.
    Yamafuji K; Watanabe M
    Adv Exp Med Biol; 1983; 156():409-18. PubMed ID: 6552847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current aspects of kinin research. I. Potentiation and blocking of biological kinin activity].
    Vogel R; Werle E; Zickgraf-Rüdel G
    Z Klin Chem Klin Biochem; 1970 May; 8(3):177-85. PubMed ID: 4919197
    [No Abstract]   [Full Text] [Related]  

  • 24. [Nature of the kinins formed in human plasma by pancreatic kallikrein, glass contact and acid treatment].
    Garbe G; Vogt W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(1):119-26. PubMed ID: 4231710
    [No Abstract]   [Full Text] [Related]  

  • 25. [Some properties and substrate nature of purified rabbit kininogen].
    Egorova TP; Makarova OV; Paskhina TS
    Biokhimiia; 1969; 34(3):610-9. PubMed ID: 5821748
    [No Abstract]   [Full Text] [Related]  

  • 26. [Kinin liberation from human plasma by streptokinase].
    Fischer G; Udermann H
    Arzneimittelforschung; 1970 Apr; 20(4):580-4. PubMed ID: 5467827
    [No Abstract]   [Full Text] [Related]  

  • 27. [Discussion of methods for the determination of the kallikrein-kinin system].
    Trautschold I
    Hoppe Seylers Z Physiol Chem; 1968 Jul; 349(7):925-6. PubMed ID: 5725826
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for the location of methionyl-lysyl-bradykinin moieties at the carboxyl terminus and inside of bovine kininogen-I.
    Yano M; Nagasawa S; Suzuki T
    Biochem Biophys Res Commun; 1970 Aug; 40(4):914-8. PubMed ID: 5495739
    [No Abstract]   [Full Text] [Related]  

  • 29. [ON SUBSTRATES AND REACTION PRODUCTS OF THE KININ-PRODUCING ENZYMES TRYPSIN, SERUM- AND PANCREATIC KALLIKREIN AND CROTALUS VENOM].
    HABERMANN E; BLENNEMANN G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Nov; 249():357-73. PubMed ID: 14338851
    [No Abstract]   [Full Text] [Related]  

  • 30. Formation and function of kinins.
    Eisen V
    Rheumatology; 1970; 3():103-68. PubMed ID: 4945765
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinin-like activity in bovine milk.
    Leach BE; Blalock CR; Pallansch MJ
    J Dairy Sci; 1967 May; 50(5):763-4. PubMed ID: 6038884
    [No Abstract]   [Full Text] [Related]  

  • 32. Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogens.
    Stuardo M; Gonzalez CB; Nualart F; Boric M; Corthorn J; Bhoola KD; Figueroa CD
    J Leukoc Biol; 2004 Apr; 75(4):631-40. PubMed ID: 14742641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A system for the study of kallikreins.
    Stewart JM; Morris DH
    Adv Exp Med Biol; 1979; 120A():213-8. PubMed ID: 495310
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.
    Greene LJ; Camargo AC; Krieger EM; Stewart JM; Ferreira SH
    Circ Res; 1972 Sep; 31(9):Suppl 2:62-71. PubMed ID: 4341481
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of kininogen and degradation of bradykinin by PC12 cells.
    Dendorfer A; Wellhöner P; Braun A; Roscher AA; Dominiak P
    Br J Pharmacol; 1997 Dec; 122(8):1585-92. PubMed ID: 9422802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isolation and identification of 2 kinin-yielding, peptic cleavage products from bovine plasma].
    Hochstrasser K; Werle E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):28. PubMed ID: 4172904
    [No Abstract]   [Full Text] [Related]  

  • 37. [Potentiation of kinin activity by products of proteolytic protein degradation].
    Czokalo M; Buluk K; Zuch A; Lukjan H; Tymińska-Brzósko R
    Pol Tyg Lek; 1974 Nov; 29(46):1965-8. PubMed ID: 4279398
    [No Abstract]   [Full Text] [Related]  

  • 38. Tryptic peptides from rabbit and bovine albumin enhancing the effect of bradykinin.
    Weyers R; Hagel P; Das BC; van der Meer C
    Biochim Biophys Acta; 1972 Sep; 279(2):331-55. PubMed ID: 5082504
    [No Abstract]   [Full Text] [Related]  

  • 39. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
    Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
    Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin.
    Wintroub BU; Goetzl EJ; Austen KF
    J Exp Med; 1974 Sep; 140(3):812-24. PubMed ID: 4547125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.